mewburn-logo-white mewburn-logo
  • About us
    • About us
    • Working with our Munich Office
    • Our AI Strategy & Action Plan
    • Who we work with
    • How we work with our clients
    • The Mewburn Ellis culture
    • Community giving
    • Inclusion & diversity
      • Inclusion & diversity
      • Gender Pay Gap
      • Women in IP
    • Sustainability
    • Join Mewburn Ellis
      • Join Mewburn Ellis
      • Vacancies
    • Graduate training programme
    • Business partners
      • Business partners
      • Code of conduct
      • Diversity policy
      • Environmental policy
  • Our People
    • Our People
    • View All People
    • Our Leadership Team
  • About you
    • Who we work with
    • I'm an attorney/law firm
    • I'm a university/R&D
    • I'm a corporate
    • I'm an SME
    • I'm a start up/spin out
  • Which service?
    • Services
    • I want to patent an invention
      • I want to patent an invention
      • Chemistry Patents
      • Engineering Patents
      • Life Sciences Patents
      • Patent Disputes
      • Patent Renewals
      • European Patent Validations
      • Pharma Patent Extensions & Regulatory Exclusivity
    • I want to protect a brand
      • I want to protect a brand
      • Register a trade mark
      • Trade mark disputes
      • Trade mark renewals
      • I want to change a domain name
    • I want to protect my design
      • Register a Design
      • Design Renewals
    • I need help with contentious proceedings
      • Contentious proceedings
      • post grant proceedings
      • oppositions or appeals
      • IP litigation or disputes
      • The Unified Patent Court
    • I need some commercial advice
    • I need to validate my European patent
    • I want to renew my ip rights
  • Spotlight on
    • Health
      • Advanced therapeutics
      • Animal health
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future food
      • Medical technologies
      • Microbiome
      • Pharmaceuticals
      • Plants
      • Precision medicine
      • Speciality pharma
    • Technology
      • Artificial Intelligence (AI)
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future mobility
      • Green & sustainable technologies
      • Medical technologies
      • New Nuclear Technologies
      • Quantum Technology
      • Software
      • Space Technology
    • Industry
      • 2d materials
      • Automotive
      • Energy storage
      • Green tech
      • Marine & ocean engineering
      • Medical devices
      • Polymers
      • Pharmaceuticals
      • Plants
      • Speciality pharma
      • Synthetic biology
    • Intellectual property
      • Brexit
      • Green ip
      • Ip litigation
      • Oppositions - chemistry & materials
      • Oppositions - engineering & ICT
      • Oppositions - life sciences
      • UPC
      • Women in ip
  • Knowledge hub
    • Law & practice library
    • News, insights & features
    • Special reports
    • Films
    • Events and Webinars
  • Contact us
    • Offices
      • 8 Bishopsgate
    • Residencies
  • en
  • zh-hans
  • germany
  • ja
  • ko
  • About us
    • About us
    • Working with our Munich Office
    • Our AI Strategy & Action Plan
    • Who we work with
    • How we work with our clients
    • The Mewburn Ellis culture
    • Community giving
    • Inclusion & diversity
      • Inclusion & diversity
      • Gender Pay Gap
      • Women in IP
    • Sustainability
    • Join Mewburn Ellis
      • Join Mewburn Ellis
      • Vacancies
    • Graduate training programme
    • Business partners
      • Business partners
      • Code of conduct
      • Diversity policy
      • Environmental policy
  • Our People
    • Our People
    • View All People
    • Our Leadership Team
  • About you
    • Who we work with
    • I'm an attorney/law firm
    • I'm a university/R&D
    • I'm a corporate
    • I'm an SME
    • I'm a start up/spin out
  • Which service?
    • Services
    • I want to patent an invention
      • I want to patent an invention
      • Chemistry Patents
      • Engineering Patents
      • Life Sciences Patents
      • Patent Disputes
      • Patent Renewals
      • European Patent Validations
      • Pharma Patent Extensions & Regulatory Exclusivity
    • I want to protect a brand
      • I want to protect a brand
      • Register a trade mark
      • Trade mark disputes
      • Trade mark renewals
      • I want to change a domain name
    • I want to protect my design
      • Register a Design
      • Design Renewals
    • I need help with contentious proceedings
      • Contentious proceedings
      • post grant proceedings
      • oppositions or appeals
      • IP litigation or disputes
      • The Unified Patent Court
    • I need some commercial advice
    • I need to validate my European patent
    • I want to renew my ip rights
  • Spotlight on
    • Health
      • Advanced therapeutics
      • Animal health
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future food
      • Medical technologies
      • Microbiome
      • Pharmaceuticals
      • Plants
      • Precision medicine
      • Speciality pharma
    • Technology
      • Artificial Intelligence (AI)
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future mobility
      • Green & sustainable technologies
      • Medical technologies
      • New Nuclear Technologies
      • Quantum Technology
      • Software
      • Space Technology
    • Industry
      • 2d materials
      • Automotive
      • Energy storage
      • Green tech
      • Marine & ocean engineering
      • Medical devices
      • Polymers
      • Pharmaceuticals
      • Plants
      • Speciality pharma
      • Synthetic biology
    • Intellectual property
      • Brexit
      • Green ip
      • Ip litigation
      • Oppositions - chemistry & materials
      • Oppositions - engineering & ICT
      • Oppositions - life sciences
      • UPC
      • Women in ip
  • Knowledge hub
    • Law & practice library
    • News, insights & features
    • Special reports
    • Films
    • Events and Webinars
  • Contact us
    • Offices
      • 8 Bishopsgate
    • Residencies
  • All topics
  • Forward
  • Artificial Intelligence
  • Battery Technologies
  • Bioinformatics
  • Brexit
  • Chemistry
  • Commercial Advice
  • Community
  • COVID-19
  • Designs
  • Energy Storage
  • Engineering
  • EU Unitary Patent / Unified Patent Court
  • FemTech
  • Future Food Tech
  • Future Mobility
  • Graphene & 2D Materials
  • Green Tech
  • ICT
  • Life Sciences
  • Litigation
  • Marine & Ocean Engineering
  • Materials
  • MedTech
  • Microbiome
  • Nature based materials
  • Nuclear
  • On-Demand
  • Oppositions
  • Patents
  • Pharmaceuticals
  • Plants
  • Polymers
  • Polymer recycling
  • Precision Medicine
  • Quantum Computing
  • SME
  • Software
  • Space Tech
  • Synthetic Biology
  • Trade Marks
Covid autumn booster vaccine 2023: the switch to mono-valent vaccines
Nick Sutcliffe - October 3, 2023

Covid autumn booster vaccine 2023: the switch to mono-valent vaccines

Autumn 2023 sees another round of COVID-19 booster jabs across the UK for vulnerable people.

mRNA cancer vaccine shows efficacy in clinical trial
Nick Sutcliffe - December 20, 2022

mRNA cancer vaccine shows efficacy in clinical trial

Moderna and Merck announced in a mid-December 2022 press release that its mRNA cancer vaccine ...

Horizons in vaccine production
Tanis Keirstead - April 14, 2022

Horizons in vaccine production

The scramble for a coronavirus vaccine over the last two years has demonstrated how important ...

A much-needed boost: the future of coronavirus vaccines
Tanis Keirstead - April 4, 2022

A much-needed boost: the future of coronavirus vaccines

Just over two years after our first blog on Covid-19, it appears that the disease is here to stay. ...

Digital therapeutics: the rise of digital health technologies during the Covid-19 pandemic
Camille Terfve - November 12, 2021

Digital therapeutics: the rise of digital health technologies during the Covid-19 pandemic

There is no denying that the Covid-19 pandemic has reshaped many aspects of our lives. Those lucky ...

Healthy eating means more than just a balanced diet: future foods and fighting the risk of infection
Samuel Hart - June 3, 2021

Healthy eating means more than just a balanced diet: future foods and fighting the risk of infection

Human health is inextricably linked to food – not least because eating a healthy diet is known to ...

A sense of hope with graphene-based COVID-19 detection
Nathan Zhang - May 4, 2021

A sense of hope with graphene-based COVID-19 detection

With mass COVID-19 vaccinations being rolled out by countries across the world, there may be an end ...

COVID-19 win for AI pharma farmers
Joseph Newcombe - April 26, 2021

COVID-19 win for AI pharma farmers

The vaccine roll-out is in action all over the world. Nevertheless, given the propensity of ...

EPO 2020 Patent Index - key trends
Sarah Harvey - March 23, 2021

EPO 2020 Patent Index - key trends

The European Patent Office (EPO) recently published its 2020 Patent Index which provides a ...

SARS-CoV-2 variants – reasons to be optimistic
Adam Gregory - January 29, 2021

SARS-CoV-2 variants – reasons to be optimistic

In recent weeks and months, several highly-transmissible variants of SARS-CoV-2 (the virus that ...

Will the COVID-19 vaccines induce more robust immunity than infection with SARS-Cov-2 itself?
Eliot Ward - December 21, 2020

Will the COVID-19 vaccines induce more robust immunity than infection with SARS-Cov-2 itself?

Respiratory viruses such as coronaviruses are notorious for evading the immune system[1] and, in ...

AstraZeneca/Oxford University vaccine shows efficacy against SARS-CoV-2
Nick Sutcliffe - November 25, 2020

AstraZeneca/Oxford University vaccine shows efficacy against SARS-CoV-2

AstraZeneca/Oxford University have announced that their SARS-CoV-2 candidate vaccine AZD1222 showed ...

Protective barriers against COVID-19 – what’s behind the screen?
Joseph Newcombe - November 19, 2020

Protective barriers against COVID-19 – what’s behind the screen?

Since the outbreak of the COVID-19 pandemic there has been a significant increase in the demand for ...

And then there were two – Moderna SARS-CoV-2 vaccine shows efficacy
Nick Sutcliffe - November 16, 2020

And then there were two – Moderna SARS-CoV-2 vaccine shows efficacy

Moderna have announced that their SARS-CoV-2 vaccine candidate mRNA1273 showed efficacy in a first ...

Pfizer and BioNTech vaccine provides protection against SARS-CoV-2
Nick Sutcliffe - November 13, 2020

Pfizer and BioNTech vaccine provides protection against SARS-CoV-2

Pfizer/BioNTech have now released more data from the Phase 3 clinical trial of the BNT162b2 ...

COVID-19 rescue act or major overhaul of the UK insolvency framework?
Emma Kennaugh-Gallacher - November 6, 2020

COVID-19 rescue act or major overhaul of the UK insolvency framework?

As we go into England’s second national lockdown of this COVID-19 pandemic, greater numbers of ...

Hummingbird Bioscience to start clinical trials for SARS-CoV-2-targeted antibody, HMBD-115
Adam Gregory - October 27, 2020

Hummingbird Bioscience to start clinical trials for SARS-CoV-2-targeted antibody, HMBD-115

Our client, Hummingbird Bioscience, has received regulatory authorisation to initiate clinical ...

Facing facts: How the rise of face coverings has brought IP risks
Kate O'Rourke - September 15, 2020

Facing facts: How the rise of face coverings has brought IP risks

Forward: features discuss and celebrate the best of innovation and exploration from the scientific ...

Combatting COVID-19: does Vitamin D have a role to play?
Melodie Richardson - September 4, 2020

Combatting COVID-19: does Vitamin D have a role to play?

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), better known as COVID-19 or simply ...

Team Home or Team Office: the challenges of a COVID-19 secure workplace
Kate O'Rourke - August 11, 2020

Team Home or Team Office: the challenges of a COVID-19 secure workplace

Solicitor Hilda-Georgina Kwafo-Akoto discusses how the COVID-19 pandemic could be a catalyst for ...

“Test, test, test” – the importance of diagnostics in pandemic preparedness
Rachel Oxley - July 9, 2020

“Test, test, test” – the importance of diagnostics in pandemic preparedness

While the world waits for a vaccine to be developed and approved for use against the COVID-19 ...

Industry makeover: how the cosmetics industry has been affected by COVID-19
Jacqueline Pang - June 26, 2020

Industry makeover: how the cosmetics industry has been affected by COVID-19

The cosmetics industry has undergone a major transformation during the ongoing COVID-19 crisis. ...

Cellular immunity – a contributor to COVID-19 “dark matter”?
Rebecca Tollervey - June 25, 2020

Cellular immunity – a contributor to COVID-19 “dark matter”?

Immunologist Karl Friston of University College London has theorized that there may be ...

Can CRISPR help us in the fight against COVID-19?
Sean Constable - June 10, 2020

Can CRISPR help us in the fight against COVID-19?

As countries across the world continue to face widespread disruption in the face of the COVID-19 ...

Links between COVID-19 severity and the immune system
Tanis Keirstead - June 5, 2020

Links between COVID-19 severity and the immune system

The mechanism through which SARS-CoV-2, the virus that causes COVID-19, infects cells is known. The ...

Branding in times of crisis: It’s time to make your mark meaningful
Rebecca Anderson-Smith - June 5, 2020

Branding in times of crisis: It’s time to make your mark meaningful

David Benady explains why a brand based on solid values is now a business’s most powerful asset.

Is faster drug development likely to become the “new normal?”
Julie Carlisle - June 1, 2020

Is faster drug development likely to become the “new normal?”

As part of our Thought Leaders series, Sarah Kostiuk-Smith explores whether faster drug development ...

COVID-19: Suspension of Surcharge for Late Payment of Renewal Fees at the EPO
Willum Wytenburg - May 29, 2020

COVID-19: Suspension of Surcharge for Late Payment of Renewal Fees at the EPO

The European Patent Office (EPO) now has a dedicated webpage regarding their response to COVID-19; ...

Contact tracing – our route out of the coronavirus (COVID-19) lockdown?
Alex Burns - May 28, 2020

Contact tracing – our route out of the coronavirus (COVID-19) lockdown?

It appears that the United Kingdom is now past the peak of the COVID-19 infection curve, and the ...

Electronic signatures, “the new normal”?
Frederick Steele - May 22, 2020

Electronic signatures, “the new normal”?

The COVID-19 pandemic and resulting social distancing has meant that in-person signing of documents ...

New coronavirus (COVID-19) test allows rapid detection of neutralising antibodies
Adam Gregory - May 15, 2020

New coronavirus (COVID-19) test allows rapid detection of neutralising antibodies

Our client, Duke-NUS, has helped to develop a new, rapid serological test for determining whether ...

From airbags to medical gowns – Autoliv continues to save lives to help fight against coronavirus (COVID-19)
Simon Parry - May 12, 2020

From airbags to medical gowns – Autoliv continues to save lives to help fight against coronavirus (COVID-19)

Companies around the world are pivoting to help meet global shortages of personal protection ...

Counterfeit contagion: fraudulent activities spread amid coronavirus (COVID-19)
Kate O'Rourke - May 6, 2020

Counterfeit contagion: fraudulent activities spread amid coronavirus (COVID-19)

The COVID-19 outbreak has caused disruption to manufacturing operations on a global scale. Lockdown ...

How computer modelling has been used during the coronavirus (COVID-19) outbreak to inform political decisions
Stephen Gill - May 1, 2020

How computer modelling has been used during the coronavirus (COVID-19) outbreak to inform political decisions

Throughout the emergence and continued spread of the novel coronavirus, COVID-19, policy makers ...

Coronavirus (COVID-19) extension at the EPO: Part 2
Willum Wytenburg - May 1, 2020

Coronavirus (COVID-19) extension at the EPO: Part 2

The European Patent Office (EPO) now has a dedicated webpage regarding their response to COVID-19; ...

BerGenBio’s bemcentinib selected for fast track as potential treatment for coronavirus (COVID-19)
Robert Andrews - April 30, 2020

BerGenBio’s bemcentinib selected for fast track as potential treatment for coronavirus (COVID-19)

In the fight against the coronavirus pandemic, bemcentinib produced by BerGenBio has been selected ...

The power of trade marks: social distancing logos during the coronavirus (COVID-19) pandemic
Rebecca Anderson-Smith - April 30, 2020

The power of trade marks: social distancing logos during the coronavirus (COVID-19) pandemic

We are all now familiar with the social distancing guidelines set out by the World Health ...

Graphene masks: facing up to coronavirus (COVID-19)
Genevieve Pugh - April 28, 2020

Graphene masks: facing up to coronavirus (COVID-19)

Since the development and isolation of graphene by researchers at Manchester University in 2004, ...

Temporary modification of production conditions for PGIs and PDOs will help farmers struggling to deal with coronavirus (COVID-19)
Rebecca Anderson-Smith - April 27, 2020

Temporary modification of production conditions for PGIs and PDOs will help farmers struggling to deal with coronavirus (COVID-19)

The coronavirus lockdowns across many European countries have brought a variety of new challenges ...

Governments look to protect companies from IP enforcement during the coronavirus (COVID-19) pandemic
Andrew Pitts - April 24, 2020

Governments look to protect companies from IP enforcement during the coronavirus (COVID-19) pandemic

A large effort is underway globally to ensure that there are enough mechanical ventilators ...

Coronavirus (COVID-19), big data and silver linings
Camille Terfve - April 23, 2020

Coronavirus (COVID-19), big data and silver linings

There is no denying that the COVID-19 pandemic will have tremendous practical and economic impact ...

How 3D printing is helping in the fight against coronavirus (COVID-19)
Tom Furnival - April 22, 2020

How 3D printing is helping in the fight against coronavirus (COVID-19)

In a crisis which has been defined by its pace of change, 3D printing has become a useful tool in ...

Has a cure for coronavirus (COVID-19) already been made?
Julie Carlisle - April 20, 2020

Has a cure for coronavirus (COVID-19) already been made?

Faced with the biggest global pandemic in most of our lifetimes, all around the world research ...

Antibody tests for prior infection with SARS-CoV-2 – key tools for monitoring and managing the coronavirus (COVID-19) outbreak
Adam Gregory - April 14, 2020

Antibody tests for prior infection with SARS-CoV-2 – key tools for monitoring and managing the coronavirus (COVID-19) outbreak

In recent weeks there’s been a lot of discussion in the media of antibody tests relating to ...

Crown Use during the coronavirus (COVID-19) pandemic
Matthew Naylor - April 9, 2020

Crown Use during the coronavirus (COVID-19) pandemic

As discussed in a previous blog, the UK Government has the power to authorise (either in advance, ...

Why a
Rebecca Anderson-Smith - April 9, 2020

Why a "COVID-19” trade mark should be rejected

The COVID-19 pandemic has undoubtedly forced us all to adapt our lives and business practices in ...

What use is computational biology during the coronavirus (COVID-19) pandemic?
Camille Terfve - April 6, 2020

What use is computational biology during the coronavirus (COVID-19) pandemic?

There is one obvious way in which computational biology is showing its strengths in the current ...

3D printing community responds to the coronavirus (COVID-19) challenge
Jacqueline Murphy - April 3, 2020

3D printing community responds to the coronavirus (COVID-19) challenge

The coronavirus (COVID19) pandemic has left healthcare systems globally scrambling for much needed ...

Patent infringement during a national emergency: a Coronavirus (COVID-19) perspective
Andrew Pitts - April 3, 2020

Patent infringement during a national emergency: a Coronavirus (COVID-19) perspective

Recent interesting reports highlight an emerging practice borne out of necessity in which medical ...

A*STAR and MiRXES step up in the fight against coronavirus (COVID-19)
Eliot Ward - April 2, 2020

A*STAR and MiRXES step up in the fight against coronavirus (COVID-19)

Our Singapore based-clients A*STAR (Agency for Science, Technology and Research) and MiRXES are ...

Coronavirus (COVID-19): a case study in emerging disease
Tanis Keirstead - March 24, 2020

Coronavirus (COVID-19): a case study in emerging disease

UPDATE 14 APRIL 2022: In his blog Horizons in vaccine production, we explore pressing need to ...

Vaccine platform technologies to combat emerging infectious diseases
Lucy White - March 23, 2020

Vaccine platform technologies to combat emerging infectious diseases

The SARS-CoV-2 outbreak is now a global pandemic. In a previous post, we discussed the need to act ...

Changes to our correspondence address
Richard Clegg - March 20, 2020

Changes to our correspondence address

In response to the current situation in London due to Coronavirus (COVID-19) we are redirecting all ...

Coronavirus (COVID-19) Extension at the EPO: Not ALL deadlines extended!
Willum Wytenburg - March 16, 2020

Coronavirus (COVID-19) Extension at the EPO: Not ALL deadlines extended!

Part 2 of this blog was published on 17 April 2020. Please read for the latest information. News ...

Coronavirus (COVID-19) Update
Richard Clegg - March 3, 2020

Coronavirus (COVID-19) Update

Updated: 2pm Sunday 1st November 2020

More

  • Slavery Act
  • Legal Notices
  • Terms and Conditions
  • Privacy
  • Forward Community Programme
  • Client Login
  • Join Mewburn Ellis

Follow us

Subscribe

Sign up to Forward: news, insights and features from Mewburn Ellis

Contact

  • mail@mewburn.com
  • London:

    +44 (0)20 7776 5300
  • Bristol:

    +44 (0)117 945 1234
  • Cambridge:

    +44 (0)1223 420383
  • Manchester:

    +44 (0)161 2477 722
  • Munich:

    +49 (0)89 244 459800

Copyright © 2025 Mewburn Ellis. All rights reserved. Terms and Conditions & Online Privacy